Source: Eur Respir J, 55 (6) 2001514; 10.1183/13993003.01514-2020
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Richard E.K. Russell, Kay Wang. Finding the true prevalence of obstructive lung disease: two steps forward and one step back. Eur Respir J, 55 (6) 2001514; 10.1183/13993003.01514-2020

Member's Comments

No comment yet.

Related content which might interest you: Idiopathic pulmonary fibrosis: another step in understanding the burden of this disease Source: Eur Respir J 2016; 48: 26-28 Year: 2016 Monitoring disease progression in COPD patients: one step beyond! Source: Eur Respir J 2014; 43: 665-667 Year: 2014 Defining severe obstructive lung disease in the biologic era: an endotype-based approach Source: Eur Respir J, 54 (5) 1900108; 10.1183/13993003.00108-2019 Year: 2019 Chronic obstructive pulmonary disease: real opportunity of 3 year respiratory function control Source: Eur Respir J 2006; 28: Suppl. 50, 626s Year: 2006 Comparison of metabolic work during the six minute walk and step test in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2006; 28: Suppl. 50, 65s Year: 2006 COPD prevalence in a random population survey: a matter of definition Source: Eur Respir J 2007; 30: 232-239 Year: 2007 Red blood cell distribution width in patients with chronic obstructive lung disease:how is changed in exacerbation? Source: International Congress 2017 – Airway disease and exacerbations Year: 2017 Risk prediction and end-points in idiopathic pulmonary fibrosis: one step at a time Source: Eur Respir J 2014; 43: 1237-1239 Year: 2014 The role of cluster analysis in defining phenotypes of obstructive airway diseases: is there a need for a new taxonomy of obstructive airway diseases? Source: Annual Congress 2011 - PG11 Update of phenotypes of asthma and COPD Year: 2011 Defining airflow limitation and chronic obstructive pulmonary disease: the role of outcome studies Source: Eur Respir J 2015; 46: 8-10 Year: 2015 Chronic obstructive pulmonary disease: current burden and future projections Source: Eur Respir J 2006; 27: 397-412 Year: 2006 Combination therapy for chronic obstructive pulmonary disease: one size fits all? Source: Eur Respir J 2003 Dec 01;22(6):874-875 Year: 2003 The scale of the problem of obstructive lung disease in Africa becomes clearer, but where are the solutions? Source: Eur Respir J, 51 (2) 1702562; 10.1183/13993003.02562-2017 Year: 2018 Chronic obstructive pulmonary disease (COPD) in children: is it possible? Source: Eur Respir J 2005; 26: Suppl. 49, 63s Year: 2005 Searching for chronic obstructive pulmonary disease in the over 65 people: suggestions for a cost-effective approach Source: Eur Respir J 2004; 24: Suppl. 48, 360s Year: 2004 Prevalence, correlates and mortality impact of chronic obstructive pulmonary disease in end stage kidney disease Source: Annual Congress 2008 - COPD - clinical and epidemiological aspects Year: 2008 Chronic obstructive pulmonary disease: current burden and future projections - Supplementary material Source: Eur Respir J 2006; 27: 397-412 Year: 2006 Impact of a single chronic obstructive pulmonary disease (COPD) exacerbation on lung function decline: Analysis of UPLIFT® Source: Annual Congress 2012 - Exacerbations of asthma and COPD: assessment, impact and novel treatments Year: 2012 Identifying cut off scores for the chronic obstructive pulmonary disease assessment test (CAT) to predict exacerbations in COPD Source: International Congress 2017 – Primary care management of asthma and COPD Year: 2017